Renato Rjavec, Director of Products - Amplexor Life Sciences
After all the theorizing and preparing for, IDMP is suddenly real (in Europe, at least). But compliance will be a staged, iterative affair as requirements evolve.
The key, then, is to establish whether your organization is on the right path to ensure long-term alignment with the demands of IDMP. And for each company, the starting point will differ.
Join our experts in this webinar, we’ll set out the most common scenarios pharma companies will typically be starting from, exploring the options in each case.
Scenario 1: No formal RIM system currently in place
Scenario 2: Existing RIM investment: build on it – or start afresh?
Scenario 3: Single RIM vendor vs best-of-breed applications – can IDMP solution be implemented into the existing RIM landscape?
In the webinar, we’ll work through each scenario, discussing the different options – and explore the merits of performing a low-risk/low-cost IDMP proof-of-concept alongside those existing RIM set-ups to check the preferred choice is fit for purpose.